Navigation Links
Narconon Reveals How Cannabis Cravings Drive European Drug Trends
Date:8/30/2013

(PRWEB) August 30, 2013

A new report from the European Monitoring Center for Drugs and Drug Addiction provides a new, overall look at the rates of drug abuse and trafficking across Europe. An examination of that report shows how prominently cannabis figures into current trends.

First, cannabis is the most-used drug across the European Union. More than three million Europeans abuse this drug every day. The Czech Republic measured the highest rates of abuse, with 42% of 15 and 16 year olds having tried the drug.

Across all of Europe, it’s estimated that more than 15 million people 15 to 34 years of age have consumed this drug in the last year.

While cannabis has long been the market leader, the synthetic cannabis market has been growing rapidly in the last few years. Synthetic cannabinoids (cannabis-like) are not similar to cannabis in their chemistry, but rather in the way they interact with the body. Synthetic cannabinoids can be extremely potent and may contain a variety of different ingredients. There is no predicting the effects when a person choses one of these substances.

"While some synthetic cannabinoids are illegal, there are always new substances of this type hitting the market," said Clark Carr, president of Narconon International. "It is impossible for legislative bodies to keep up with this trend. Currently, there is one new psychoactive substance per week being reported to the European early warning system."

Each year in Europe, there are more than a million seizures of drugs, with cannabis accounting for nearly three out of four seizures. Important to note is that seizures of herbal cannabis have more than tripled in Europe since 2001. Seizures of resin cannabis (hashish) remain high at more than 300,000 annually.

In addition, nearly every country has reported seizures of multi-kilogram quantities of synthetic cannabinoid agents, most of it being trafficked from Asia to Europe. About these synthetics, the new report, titled European Drug Report, Trends and developments, notes that: "Many of the products on sale contain mixtures of substances, and the lack of pharmacological and toxicological data means it is hard to speculate on long term health implications of use, but increasingly data shows that some of these substances cause problems requiring clinical interventions, and fatalities have been recorded."

"Users choosing these new, unpredictable drugs are playing with fire," said Carr. "The more parents talk to their children about the problems related with use of synthetics, the better. It would be smart for parents to also mention the fact that 60,000 Europeans each year are entering drug rehab centers to get help for cannabis addictions, proving that this drug also creates severe problems for the abuser."

The primary countries reporting high levels of treatment for cannabis addiction are the UK, Germany, Spain, France, Italy and the Netherlands.

"Our Narconon centers in Europe can, of course, help these people who have suffered damage due to abuse of these drugs, but when parents can prevent drug abuse by their children, then they can avoid the need for rehab," concluded Carr.

For more information on the Narconon drug rehab program, call 1-800-775-8750.

Reference
http://www.emcdda.europa.eu

Read the full story at http://www.prweb.com/releases/european-cannabis/drug-trends/prweb11079527.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. Narconon Louisiana Supports United Nations International Day Against Drug Abuse and Illicit Trafficking
2. Mary Rieser of Narconon Georgia Speaks Out For United Nations International Day Against Drug Abuse
3. Narconon Arrowhead Celebrates Twenty Years of Service to More than Ten Thousand Recovering Addicts
4. Narconon Offers New Tool to Help Families Find Faster Solutions to Addiction
5. Narconon Arrowhead Welcomes International Drug Prevention Specialist Who Brings Message of Hope to Clients
6. Narconon International Pledges Wholehearted Support for Rx Drug Abuse Summit Cause: “Make an Impact”
7. International Narconon Directors Join Parents of Graduates to Celebrate Release of 40 Years of Positive Outcome Studies
8. Narconon Arrowhead Volunteers Provide Enthusiastic Support for Pride in McAlester Celebration
9. Narconon Arrowhead Welcomes Worldwide Management Staff for Inspirational Tour
10. LAPD Singles Out Narconon Drug Prevention and Education for Special Commendation
11. Recent Release of ‘The Narconon Program - 40 Years of Evidence of Recovery’ Reveals Earlier Unfound Narconon Connecticut Study
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/31/2016)... ... , ... The Global Wellness Summit (GWS), an annual conference for ... wellness, travel, spa and beauty in Europe. The organization asked its partner experts in ... and researchers - to forecast where wellness is headed in Europe. Predictions range from ...
(Date:5/31/2016)... ... May 31, 2016 , ... Interest is on the ... tool and as an orthogonal tool for RNAi hit validation. A key reason may ... guide RNAs—allows rapid generation of CRISPR RNA (crRNA) collections in arrayed formats. , ...
(Date:5/31/2016)... ... , ... Dr. Charles A. Ditta attained his Doctor of Medical Dentistry Degree ... 1986, where he graduated in the top ten percentile of his class. Dr. Ditta ... He has been a member in good standing for thirty years in the American ...
(Date:5/30/2016)... ... May 30, 2016 , ... As the CDC relaxes its stance on traditional ... to keep their households lice free. , According to a May 26 article ... keep kids in the classroom despite the fact that they may be harboring an ...
(Date:5/29/2016)... ... ... Whole Health Supply is happy to announce the favorable reception of its ... new style of nail clipper has a wider jaw opening that is useful for ... actual handle is 2.5mm thick to accommodate the cutting force. This is the maximum ...
Breaking Medicine News(10 mins):
(Date:5/30/2016)... , May 30, 2016 ... H1 2016" market research report with comprehensive information ... with comparative analysis at various stages, therapeutics assessment ... of administration (RoA) and molecule type, along with ... It also reviews key players involved in the ...
(Date:5/27/2016)... 2016 Hutchison China MediTech ... on the highly lucrative global oncology and immunology ... potential first-in-class or best-in-class tyrosine kinase inhibitor (TKI) ... strategic partners. HCM,s profitable Chinese healthcare business continues ... expect progress of the mid-to-late-stage pipeline during 2016-17 ...
(Date:5/26/2016)... 2016 A key trend that ... emergence of new treatments. Cardax, a development stage life ... The therapy is expected to fulfil large unmet medical ... conducting studies to develop new treatments for osteoarthritis. One ... involved in osteoarthritis are being investigated, and early trials ...
Breaking Medicine Technology: